Simon Quick Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-167
Closed -$2K 323
2022
Q1
$2K Buy
167
+17
+11% +$358 ﹤0.01% 339
2021
Q4
$5K Hold
150
﹤0.01% 334
2021
Q3
$7K Hold
150
﹤0.01% 366
2021
Q2
$6K Hold
150
﹤0.01% 398
2021
Q1
$7K Hold
150
﹤0.01% 405
2020
Q4
$8K Hold
150
﹤0.01% 379
2020
Q3
$6K Hold
150
﹤0.01% 358
2020
Q2
$5K Hold
150
﹤0.01% 358
2020
Q1
$4K Hold
150
﹤0.01% 365
2019
Q4
$4K Buy
+150
New +$3.57K ﹤0.01% 513

Other funds holding NEO

Simon Quick Advisors's NEO Position: Q2 2022 in Review

Simon Quick Advisors sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 167 shares — an estimated $2K sold.

Simon Quick Advisors first reported a position in NEO in Q4 2019 and held it in 10 quarters. The position peaked at $8K in Q4 2020. 239 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

  • Simon Quick Advisors reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
  • Simon Quick Advisors sold 167 NeoGenomics shares in Q2 2022, an estimated $2K.
  • Simon Quick Advisors first reported a position in NeoGenomics in Q4 2019 and held it in 10 quarters.
  • Simon Quick Advisors's NeoGenomics position peaked at $8K in Q4 2020.
  • 239 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Simon Quick Advisors's 13F filing for Q2 2022, filed 8 Aug 2022.